<DOC>
	<DOCNO>NCT00436059</DOCNO>
	<brief_summary>The primary objective study investigate change bone remodel Velcade treatment .</brief_summary>
	<brief_title>The Efficacy Velcade Bone Tissue During Myelomatosis ( Bone Marrow Cancer )</brief_title>
	<detailed_description>20 patient include study 2 year period . Before , treatment measure NTX-I , CTX-I , CTX-MMP , bALP , DKK-1 , PINP , TRAcP PTH . NTX , CTX CTX-MMP measure estimate bone degradation . TRAcP measure estimate activity osteoclast . bALP DKK-1 measured evaluate activity osteoblasts PINP measure marker new bone formation . PTH measure order evaluate positive effect observe bone formation relation velcade treatment due pulsative way velcade administer . The effect velcade treatment evaluate x-ray , bone marrow m-component .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Bone Marrow Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<criteria>Previously untreated multiple myeloma Use bisfosfonates</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>